New model-of-care improves Type 2 Diabetes outcomes in Indigenous Australians
An innovative model-of-care for Indigenous Australians in remote communities with Type 2 Diabetes has shown to significantly improve sugar management. Diabetes affects Indigenous Australians at more than three to four times the rate of non-Indigenous Australians.
A study known as the Lower Sugar Study found that weekly Exenatide-LAR combined with a weekly nurse review demonstrated greater improvements in sugar levels, highlighting its potential for use in remote communities.
A trial of this model found that it was associated with greater clinic attendance and willingness to receive care. It is expected these findings will contribute to improved Indigenous health outcomes.